Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

Product portfolio
Potentially strong market reviews
Competitive analytics
Prospect partners
Mergers and acquisitions project data
Latest trends across a particular industry area
Research and development strategies
The analysis of new customers
A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853

Sort by:

Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 69 pages

Reverse Transcriptase (EC 2.7.7.49) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Reverse Transcriptase (EC 2.7.7.49) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Reverse Transcriptase (EC 2.7.7.49) Drugs in Developm...

May 2022 132 pages

Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 38 pages

Rhinosinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Rhinosinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Rhinosinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 59 pages

Rho Kinase (Rho Associated Coiled Coil Forming Protein Kinase or ROCK or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Rho Kinase (Rho Associated Coiled Coil Forming Protein Kinase or ROCK or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Rho...

May 2022 64 pages

Rhodopsin (Opsin 2 or OPN2 or RHO) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Rhodopsin (Opsin 2 or OPN2 or RHO) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Rhodopsin (Opsin 2 or OPN2 or RHO) Drugs in Developmen...

May 2022 38 pages

Ribonucleoside Diphosphate Reductase (Ribonucleotide Reductase or RRM or EC 1.17.4.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ribonucleoside Diphosphate Reductase (Ribonucleotide Reductase or RRM or EC 1.17.4.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Rib...

May 2022 60 pages

Rift Valley Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Rift Valley Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Rift Valley Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 35 pages

RNA Directed RNA Polymerase (EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

RNA Directed RNA Polymerase (EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY RNA Directed RNA Polymerase (EC 2.7.7.48) Drugs...

May 2022 78 pages

Salivary Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Salivary Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Salivary Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 76 pages

Salmonella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Salmonella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Salmonella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 62 pages

Salmonella typhimurium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Salmonella typhimurium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Salmonella typhimurium Infections Drugs in Development by Stages, Target, MoA,...

May 2022 35 pages

Sarcoidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Sarcoidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sarcoidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 48 pages

Sarcoplasmic-Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Muscle Isoform or Endoplasmic Reticulum Class 1-2 Ca(2+) ATPase or SERCA2 or ATP2A2 or EC 7.2.2.10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sarcoplasmic-Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Muscle Isoform or Endoplasmic Reticulum Class 1-2 Ca...

May 2022 39 pages

Scar Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Scar Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Scar Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview o...

May 2022 49 pages

Schistosomiasis mansoni Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Schistosomiasis mansoni Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Schistosomiasis mansoni Infections Drugs in Development by Stages, Target, Mo...

May 2022 36 pages

Schizoaffective Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Schizoaffective Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Schizoaffective Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 36 pages

Schwannoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Schwannoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Schwannoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 35 pages

Sciatica (Sciatic Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Sciatica (Sciatic Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sciatica (Sciatic Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 37 pages

Sclerostin (SOST) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sclerostin (SOST) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Sclerostin (SOST) Drugs in Development by Therapy Areas and Indications...

May 2022 39 pages

Seasonal Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Seasonal Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Seasonal Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 47 pages

Seasonal Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Seasonal Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Seasonal Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 92 pages

Secondary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Secondary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Secondary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 39 pages

Secondary Progressive Multiple Sclerosis (SPMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Secondary Progressive Multiple Sclerosis (SPMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Secondary Progressive Multiple Sclerosis (SPMS) Drugs in Develop...

May 2022 68 pages

Seizures Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Seizures Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Seizures Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 127 pages

Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Semaphorin 3A (Semaphorin III or Collapsin 1 or Semaphorin D or Semaphorin L or SEMA3A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY S...

May 2022 36 pages

Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sepsis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 188 pages

Septic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Septic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Septic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 49 pages

Serine-Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase B Raf (p94 or Proto Oncogene B Raf or v Raf Murine Sarcoma Viral Oncogene Homolog B1 or BRAF or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stag...

May 2022 76 pages

Serine-Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or Cell Cycle Checkpoint Kinase or CHEK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Sta...

May 2022 41 pages

Serine-Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinase 1 or DCLK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase DCLK1 (Doublecortin Domain Containing Protein 3A or Doublecortin Like And CAM Kinase Like 1 or Doublecortin Like Kinase 1 or DCLK1 or EC 2.7.11.1) Drugs in Development...

May 2022 36 pages

Serine-Threonine Protein Kinase-Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.26.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase-Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.2...

May 2022 38 pages

Serine-Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Serine/Threonine P...

May 2022 55 pages

Serine-Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine-Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine-Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas...

May 2022 38 pages

Serine-Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine-Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine-Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mo...

May 2022 37 pages

Serum Albumin (ALB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serum Albumin (ALB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Serum Albumin (ALB) Drugs in Development by Therapy Areas and Indicat...

May 2022 36 pages

Severe Combined Immune Deficiency (SCID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Severe Combined Immune Deficiency (SCID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Severe Combined Immune Deficiency (SCID) Drugs in Development by Stages...

May 2022 51 pages

Sezary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Sezary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sezary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 57 pages

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Shor...

May 2022 37 pages

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...

May 2022 95 pages

Signal Transducer And Activator Of Transcription 5 (STAT5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Signal Transducer And Activator Of Transcription 5 (STAT5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Signal Transducer And Activato...

May 2022 37 pages

Simplexvirus (HSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Simplexvirus (HSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Simplexvirus (HSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 113 pages

Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy A...

May 2022 69 pages

Skin Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 44 pages

Skin And Skin Structure Infections (SSSI) Caused By Bacteria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin And Skin Structure Infections (SSSI) Caused By Bacteria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin And Skin Structure Infections (SSSI) Caused By...

May 2022 56 pages

Skin And Skin Structure Infections (SSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin And Skin Structure Infections (SSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin And Skin Structure Infections (SSSI) Drugs in Development by Stag...

May 2022 65 pages

Skin And Soft Tissue Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin And Soft Tissue Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin And Soft Tissue Infections Drugs in Development by Stages, Target, MoA, RoA...

May 2022 43 pages

Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 47 pages

Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 60 pages

Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 135 pages